Bentley Pharmaceuticals
BNT • XNYS
Bentley Pharmaceuticals is a publicly traded company trading on XNYS, led by CEO Sachin G. Shah, with a market cap of $11.1B.
CEOSachin G. Shah
Market Cap$11.1B
Next Earnings
Upcoming earnings announcement for Bentley Pharmaceuticals
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Bentley Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Q4 2025 | $0.06 | — | $3.1B | — | — |
| Nov 13, 2025 | Q3 2025 | $0.06 | — | $2.9B | — | — |
| Aug 7, 2025 | Q2 2025 | $0.09 | — | $3.0B | — | — |
| May 8, 2025 | Q1 2025 | $0.09 | — | $2.6B | — | — |
| Feb 13, 2025 | Q4 2024 | $0.08 | — | $5.7B | — | — |
| Nov 14, 2024 | Q3 2024 | $0.08 | — | $3.0B | — | — |
| Aug 8, 2024 | Q2 2024 | $0.08 | — | $2.9B | — | — |
| May 9, 2024 | Q1 2024 | $0.08 | — | $2.6B | — | — |
| Feb 8, 2024 | Q4 2023 | $0.07 | — | $2.3B | — | — |
| Nov 9, 2023 | Q3 2023 | $0.07 | — | $1.5B | — | — |
| Aug 10, 2023 | Q2 2023 | $0.07 | — | $2.0B | — | — |
| May 11, 2023 | Q1 2023 | $0.07 | — | $1.2B | — | — |